Novozymes A/S logo

Novozymes A/S

TickerNSIS-B.COVenueCPHSectorBasic MaterialsPrimary listingBeta0.63
DKK 461.8+1.54%
FinScore60

Novozymes A/S is a Denmark-based company in the Basic Materials sector with a market capitalisation of $28.6B. Its FinScore is 60/100; its highest-scoring layer is Momentum (83) and its lowest is Value (35). The shares trade at 39.6x trailing earnings and are up 15% year to date.

Market cap
$28.6B
P/E (TTM)
39.6x
Dividend yield (TTM)
1.87%
ROE
5.8%

Share price performance

Loading chart…

About Novozymes A/S

www.novonesis.com

Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.

Profile
Sector
Basic Materials
Industry
Chemicals - Specialty
HQ
Denmark
Fiscal year-end
December
Trading currency
DKK
Reporting currency
EUR
Fundamentals updated
6 days ago
Market
Market cap
$28.6B
Shares outstanding
412.5M
P/E (TTM)
39.6x
Dividend yield (TTM)
1.87%
Beta (issuer)
0.62
Revenue (latest FY)
€4.2B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-19
Overall60
Quality62
Growth60
Value35
Momentum83
Relative Strength80

Snapshot

Ownership

As of 2026-03-31
Institutional
0.0%
Insider
—
Free float
83.5%
Top-4 institutional holders
0.0%
Shares outstanding
412.5M
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for Novozymes A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Novozymes A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Novozymes A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Novozymes A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Novozymes A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Novozymes A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.